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T 
HE genomes of several organisms are currently be- 
ing sequenced at impressive rates, but some scien- 
tists have asked whether the final products will be 
worth the effort. Here we argue from both the history of 
structural biology and some encouraging initial results that 
the answer is a resounding yes. 
There have been five overlapping stages in the growth 
of structural biology. The ancients learned much about an- 
imals and plants through comparative anatomy. A system- 
atic study of animal anatomy through dissection began in 
the  16th century. Microscopic anatomy began in the mid- 
17th century, and by the early 1900's there were detailed 
descriptions of a wide diversity of organs and organisms. 
1940--1970 saw a comparable flowering of knowledge about 
cellular fine structure and macromolecular assembly, thanks 
in part to the electron microscope. The details of macro- 
molecular structure were, however, largely invisible with- 
out crystallography, and the fruits of this technology are 
still ripening. 
Each of the above stages in the development of "anat- 
omy" has depended on a new method or approach whose 
availability led to rapid growth in structural information at 
a novel level of size or detail. An analogous situation now 
pertains to determination of DNA sequence. While the tech- 
nology for sequencing proteins and nucleic acids has been 
available for decades,  recent  improvements have made  it 
possible to learn the primary structure of DNA compara- 
tively quickly. As a result, there has been a huge increase 
in the number of labs that are sequencing DNA and an al- 
most incredible increase in the rate of sequence  acquisi- 
tion. The availability of computers fast enough to deal ex- 
peditiously with all the resulting data has permitted efficient 
analyses and comparisons of DNA sequences and of the 
polypeptides predicted from them, so the flow of informa- 
tion from acquisition to utilization for biological compari- 
sons has become both rapid and objective. The resulting 
catalogues of genes and gene products are facilitating a new 
version of all the  discriminations  that  have  traditionally 
made anatomical information useful; clearly the sixth age 
of anatomy is at hand. 
During each stage in the development of structural biol- 
ogy, the practitioners have been delighted in their new view 
of nature. Others in the scientific community have generally 
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been less enthusiastic, finding structure itself of little inter- 
est unless it can be related to function. When this goal has 
been achieved, then anatomical detail has been invaluable 
for elucidating biological mechanisms. For example, a mi- 
tochondrion  makes no sense until  its enzymes are local- 
ized relative to its membranes; a  catalytic mechanism is 
usually revealed by comparing the structure  of its active 
site with different substrate analogues bound. 
When  study of the  human genome was introduced  es- 
sentially as a grand project in anatomy, many of us were 
highly skeptical of its value. Doubt arose in part because 
sequencing for its own sake seemed so mindless, in part 
because the human genome seemed likely to contain a large 
amount of DNA whose sequence would convey little in- 
formation, and in part because it seemed that allocations 
to support this work would likely divert resources from the 
already competitive RO1  grants  that  support more con- 
ventional biomedical science. Several things have happened, 
however, to change the face of things. 
Genome Research Has Been Organized 
in Two Useful Hierarchies 
Rather than choosing a few pieces of the human DNA and 
beginning to sequence, genome researchers have organized 
their work in two important ways: (1) they have focused 
on model organisms with small genomes where there was 
already  sufficient  genetic  and  molecular  information  to 
give context and meaning to sequence data; and (2) genome 
work on each organism has begun with the generation of 
physical maps, so sequence information can be related to 
genetic maps and studies of mutant phenotype. 
One of the first major sequencing efforts has been with 
the  yeast Saccharomyces  cerevisiae,  whose  genome  was 
known to be small (~12.5 megabases [Mb]). Many yeast 
genes had already been identified by mutation, and several 
regions of this genome had  been analyzed by saturation 
mutagenesis,  which  identifies  most  genetically  recogniz- 
able loci. The frequency and size of intervening and spacer 
DNA sequences were known to be small, and physical maps 
of the genome had already been constructed. There were 
also  methods  for manipulating  this  genome  experimen- 
tally, e.g., gene replacement by homologous recombination, 
so one could  anticipate that sequence  information could 
be related to the functional consequences of mutation. When 
systematic sequencing began, the 16 S. cerevisiae chromo- 
somes were undertaken  by several yeast labs throughout 
the world. As of October 1995, over three-quarters of the 
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S. cerevisiae  http://genome.www.stanford.edu 
C. elegans  http://genome/wustl.edu/gsc/gschmpg.html 
http://www,sanger.ac.uk/Nsjj/C.elegans_Home.html. 
National Center for Biotechnology Information 
http://www.ncbi.nlm.nih.gov (This includes GenBank and the NCBI Newsletter). 
http://www.nchgr.nih.gov (National Center for Human Genome Research) 
http://www.ornl.gov/TechResources/Human_Genome/home.html  (Human Genome Management Information 
System of the Dept. of Energy, which includes "Human Genome News.") 
The Dept. of Energy's Biological  and Environmental Research Program 
http://www.er.doe.gov/production/oher/ 
[and then either hug_top.html (for human) 
or mgh_top.html (for microbial)] 
http://www.ncbi.nlm.nih.gov/dbEST  dbESTs 
Online Mendelian Inheritance in Man 
http://gdbwww.gdb.org/omim/docs/omintop.html 
General List of Many Other Genome Projects 
http://gdbwww.gdb.org/genomic_links.html 
genome was sequenced (11) and completion of the project 
is expected by the beginning of 1996. For detailed informa- 
tion about the current state of work on this and other ge- 
nomes, please see the Internet addresses given in Table I. 
Genome  research  on  more complex model  organisms 
has  again begun with  the  formation of detailed  physical 
maps and limited genomic sequencing. For the nematode, 
Caenorhabditis elegans (genome size ~100 Mb), a collec- 
tion of "cosmid" clones has been constructed, each of which 
carries tens of kilobases (kb) of exogenous DNA. Many of 
these sequences are from contiguous loci, yielding an or- 
dered library that covers much of the genome. There is now 
a C. elegans genomic library in yeast artificial chromosomes 
(YACS) as well; each of these clones contains hundreds of 
kb of DNA, so the number needed to cover a larger genome 
is manageable (8). Meanwhile, DNA sequencing has been 
going on in two centers, and the rate of new finished se- 
quence (six determinations to minimize the chances of er- 
ror) now exceeds one cosmid/day (7). Completion of this 
genome is expected by the end of 1998 (Table I). 
For model organisms with larger genomes, like fruit flies 
(genome 1.5 x  that of C. elegans) and mice (30 x  the nem- 
atode), the above strategy is being employed in an expanded 
form. Both YAC and cosmid libraries are now available to 
help map genes to specific pieces of DNA. Indeed, much 
of the  recent  work  on  the  human  genome  has  been fo- 
cused not on DNA sequencing, but on detailed chromo- 
somal mapping. Microsatellites (short segments of repeti- 
tive DNA)  are  being used  to  identify unique  molecular 
markers with  better  than  1  centimorgan resolution,  and 
physical maps are being generated with sequence-tagged 
sites (STSs) on YAC and cosmid clones. This work has sig- 
nificantly refined results from the classic methods of cyto- 
genetics, like Q  or G  banding, as well as older molecular 
mapping methods,  like  restriction  fragment length  poly- 
morphisms. The result is both a  useful map of genes re- 
lated to human diseases and tools that will be necessary 
for molecular studies of particular chromosomal regions. 
Systematic sequencing of the human genome is just now 
getting underway (Table I). 
Sequence Data Are Telling Us Surprising Things about 
Genome Structures and Functions 
Information from S. cerevisiae  and C. elegans is already tell- 
ing us interesting things about genome structure and orga- 
nization. In addition to the obvious features, like the num- 
ber of genes in a given amount of DNA, the statistics of 
gene size, and the distribution of genes among major fami- 
lies defined by sequence, things are coming to light that few 
would  have predicted.  The  sequences  from regions  sub- 
jected to saturation mutagenesis have revealed many more 
genes than were found in searches for mutants with phe- 
notypes. For example, genetic estimates predicted ~3,000 
essential genes in C. elegans (3), but estimates from genome 
sequence suggest ~13,000  (10). Presumably, the inactiva- 
tion of the  additional  genes by mutation is either irrele- 
vant for growth as we assess it in the laboratory or is "cov- 
ered" by the functions of other, unmutated genes. The work 
has also revealed novel features of genome organization: 
there are genes within introns, genes that appear to encode 
giant proteins, and clusters of genes with unknown func- 
tions (12).  While more than half the genes so far discov- 
ered by sequencing are of unknown function, ~40% of the 
genes from C.  elegans  (7), ~55%  from S.  cerevisiae  (11), 
and 58%  from the prokaryote, H.  influenzae  (6)  encode 
proteins whose  sequences  are  similar to the products  of 
genes already identified in other organisms. Clearly, there 
is much still to do in tracking down and analyzing unknown 
genes, but it is encouraging that so much sequence infor- 
mation can already be understood in some functional con- 
text  and  related  to  processes that  are  under  study else- 
where. 
Large scale studies of gene sequences have also opened 
up a  new  approach to genetic comparisons. Many genes 
from  humans  and  other  organisms  have  been  partially 
characterized by sequencing only a small part of a eDNA 
to yield an "expressed sequence tag" (EST). 1 These have 
1.  Abbreviations  used  in  this paper:  EST,  expressed sequence tag;  Mb, 
megabase; YAC, yeast artificial chromosome. 
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catalogues  of these  sequences are  expanding  by several 
hundred sequences/day (Table I). When the sequences of 
genes identified by mutation are compared with those in 
the dbESTs, it has sometimes been possible to find a sig- 
nificant similarity, thereby identifying a mammalian gene 
that corresponds to a gene already characterized in a sim- 
pler  organism,  like  a  yeast  (9).  Homologous sequences 
have now been identified in model organisms for most of 
the N50 human diseases genes that have been mapped by 
positional cloning (1, 2, 4, and Table I). There are two im- 
portant consequences of these developments: (a) the de- 
tailed  analysis  of gene  structure  and  function, which  is 
comparatively cheap and efficient in model organisms, is 
likely to  be  of direct benefit in  understanding  complex 
processes and pathologies in higher eukaryotes; and (b) it 
will be possible to study many human diseases in organisms 
whose experimental manipulation is not ethically offensive. 
The Conservation  of  Some Genes That Control 
Complex Functions Is Strong Enough That Currently 
Mysterious Aspects of Organismic Biology Are Likely to 
Profit from Genome Work 
The homeotic loci of Drosophila are widely known to play 
key roles in the hierarchical regulation of gene expression. 
Studies of homologous sequences in organisms with appar- 
ently different body plans  have more recently suggested 
that genome structure is related to the processes that regu- 
late development. For example, the genomic order of the 
homeotic "HOX" genes in several vertebrates is correlated 
with both the temporal and the positional order of their 
expression (for a  review see reference 5). This case sug- 
gests that there may be important properties of genomic 
organization  that  are  still  beyond  our  grasp.  While  se- 
quence information is unlikely to be sufficient for elucidat- 
ing these properties, it is almost certainly a prerequisite. 
There may be a parallel between the way information about 
specific genes is currently linking yeast and mammalian cell 
biology, and the way analogous information about higher 
order genome structure will illuminate developmental bi- 
ology. 
The Investment in Genome Structure by Labs 
That Are Set Up to Sequence Efficiently May Expedite 
Cell Biological Research and Save Money 
Many cell biologists who began their careers as microsco- 
pists or biochemists are now engaged in "molecular biol- 
ogy," meaning that they are cloning and sequencing the 
genes that encode proteins essential for the cellular pro- 
cesses they study. This makes sense because we have all 
witnessed the power of recombinant DNA technology for 
expediting research on proteins that are present in amounts 
too small for practical biochemistry. Moreover, the use of 
antisense RNA, gene disruptions, and transfection with mu- 
tant DNA encoding proteins with dominant negative phe- 
notypes are now important companions to antibody per- 
turbations  and  pharmacology for  the  study of complex 
processes in organisms without powerful genetics. The re- 
sult is that "cell biology" labs all over the world are now 
spending significant time and resources cloning, mapping, 
sequencing, and mutating DNA, when what they want to 
be doing (and do best) is studying the behavior of gene 
products. This work is often called "reagent construction," 
and it is now common to spend years assembling the DNA 
clones, mutants, protein fragments, and antibodies neces- 
sary to do a key cell biological experiment. For students of 
cell biology, it is almost a modern Rite of Passage to get a 
clone and sequence it, etc., in preparation for the origi- 
nally  intended  experiment.  Lamentably,  this  is  mostly 
mundane work in which daily tasks bear little relation to 
the biological problems selected for study. When one sees 
bright and energetic cell biologists dulling their enthusi- 
asm on kilobases of DNA sequence in order to get the back- 
ground information necessary to make the tools they need, 
one can't help but think that there must be a better way. 
Taken together these  observations have made us sup- 
porters of genome research. The investment of a reason- 
able fraction of our community's resources in accumulat- 
ing information about DNA sequence and organization is 
likely to pay big dividends, not only in knowledge of ge- 
nome structure but in the saving of countless hours of mo- 
lecular drudge work. A well set up sequencing lab can pro- 
duce ~2 kb of finished sequence per worker per day, while 
labs that are sequencing by hand are doing well if they get 
1/10th that amount. Moreover, the cost per base drops by 
~10-fold  when  the  work  is  done  in  a  lab  with  proper 
equipment and experience. The current rate of sequence 
collection will probably increase as technology improves, 
implying that we should continue with significant invest- 
ments in the study of genome structure for the near future. 
While those of us doing experiments may resent the expen- 
diture of money that might have helped us to stay funded, 
the resulting information will almost certainly be worth the 
investment, and the approach will probably save money. 
Even with All This Success,  There Are Problems That 
Must be Addressed by Our Scientific Community 
Enthusiasm for genome research does, however, lead to 
three problems that our community must address: (1) since 
resources are limited, the dollars spent on genome research 
must  be consistent with our current funding constraints. 
The 1995 investment in extramural research by the National 
Center  for  Human  Genome  Research  (NCHGR)  was 
~$114 million, while the Departments of Energy and of 
Agriculture spent ~$69.5 and $3.8 million, respectively, on 
genome work. The Small Business Administration spent 
$3 million, and comparatively small sums that are hard to 
determine came from other Institutes at the National In- 
stitutes of Health (NIH)  and from the National Science 
Foundation. These investments in aggregate are small rel- 
ative to the whole NIH budget (~$12 billion for 1995), but 
they are significant compared with the budget of the Na- 
tional Institute for General Medical Sciences (just over $900 
million), the agency upon which many of us rely. Given the 
importance of genome work and given the investments by 
other institutes and agencies in basic biomedical research, 
broadly defined, the current balance seems to us reason- 
able, but a greater investment in genome work would tip 
the balance. 
(2) The results from sequencing are first available to the 
sequencers themselves. With genome labs  funded by in- 
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tant to maximize the free and rapid flow of sequence infor- 
mation into the public domain, otherwise knowledge will 
be  either  wasted  or  improperly used.  Some  sequencing 
labs have been models of efficiency in making their data 
available, but others have not. The NCHGR has stipulated 
that sequence data from the labs they fund must be made 
public within 6 mos, but some labs in foreign countries are 
slower than that, and some industries attach strings to se- 
quences  they  share.  We  believe  that  efforts  should  be 
made to minimize the time to public access in order to max- 
imize the rate at which good science can be done. More- 
over, the push by both individuals and companies to profit 
from sequences and/or to restrict their use is a problematic 
trend that will take some years to sort out in the courts. In 
the  interim  we must work to minimize the  chances that 
profit motives retard scientific progress. 
(3) In the future, sequencing labs will certainly provide 
important  information,  e.g.,  the  genome  structures  for 
model  organisms,  humans,  and  important  pathogens,  as 
well as the  mapping of human disease  genes.  With  such 
longevity, however, sequencing labs may tend to become 
entrenched, so their lifetimes exceed their utility. It is im- 
possible to say now when enough genome work will have 
been done, but there is an obvious analogy with a learning 
curve. Sequencing centers may want to go on from human 
to aardvark, caiman, and dodo, expanding our knowledge 
of evolution, phylogeny, and extinction. The community of 
biologists will have to recognize when new knowledge from 
new sequences has begun to plateau and rein in the rate of 
spending. Sequencing programs must be structured so they 
can shrink  as their value diminishes,  giving way to more 
experimentally oriented biology. 
That said, it is clear that future biologists will be working 
in an environment defined by a wondrous wealth of infor- 
mation  about  genome  structure.  It  is  mind  boggling  to 
think of the ways in which our experimental lives will be 
changed as a result. No field of biology will be untouched, 
and a whole new generation of experimental approaches 
will likely emerge to help justify the investments that are 
now being made in sequence acquisition and analysis. 
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